USA TODAY - FDA looks into Singulair, risks of suicidal thoughts
The Food and Drug Administration is investigating anecdotal reports that people who use Singulair, the popular asthma and allergy drug, are at greater risk for suicidal thoughts and suicide.
Singulair is a pill prescribed to treat asthma and hay fever symptoms such as sneezing and a nose that is stuffy, runny or itchy. It blocks an inflammation pathway in the body that can cause both asthma and allergy symptoms.
It was approved for treating asthma in 1998 and to treat seasonal allergy symptoms in 2003.
In the past year, drugmaker Merck of Whitehouse Station, N.J., has added tremors, depression, suicidal thinking and behavior, and anxiety to the list of possible adverse side effects it gives doctors about the drug.
Most Popular
5 Regular Mistakes In Public Speaking
3 Questions No Job Seeker Ever Wants To Be Asked?
10 Jobs That Pay $30 An Hour
13 Job Interview Mistakes To Avoid
Creating Innovative New Growth Businesses Need Not Be as Random or Risky as Has Been Thought
Singulair had sales of $4.3 billion last year and has been used by “millions,” says Merck’s George Philip, who directs Singulair product development.
The FDA has asked Merck …
Read the full article with a Free Trial at MyWire.
